2020
DOI: 10.1101/2020.06.02.129486
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

In vitroandin vivocharacterization of a recombinant rhesus cytomegalovirus containing a complete genome

Abstract: In vitro and in vivo characterization of a recombinant1 rhesus cytomegalovirus containing a complete genome 2 3 Abstract (300 words) 42 Cytomegaloviruses (CMVs) are highly adapted to their host species resulting in strict species 43 specificity. Hence, in vivo examination of all aspects of CMV biology employs animal models 44 using host-specific CMVs. Infection of rhesus macaques (RM) with rhesus CMV (RhCMV) has 45 been established as a representative model for infection of humans with HCMV due to the close 46… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 96 publications
0
3
0
Order By: Relevance
“…We next asked the question of whether abrogating both the PRC and non-PRC-related immune programming activities of Rh157.5 and Rh157.4 was sufficient to convert a wildtype-like RhCMV, with conventional MHC-Ia-restricted CD8 + T cell targeting, to a 68-1-like vector with exclusively MHC-IIand MHC-E-restricted CD8 + T cell responses. Using sequence information from primary RhCMV isolates, including the original 68-1 isolate 17, we reconstructed a full length RhCMV clone (RhCMV FL) in which all suspected deletions, inversions, frameshifts and premature termination codons affecting viral open reading frames were repaired and the Rh13.1 open reading frame (ORF) was replaced by an SIVgag insert (18). RhCMV FL has robust in vivo spread (18), and as expected for a wildtype genetic configuration (9), elicits MHC-Ia-restricted, CD8 + T cell responses ( Fig.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…We next asked the question of whether abrogating both the PRC and non-PRC-related immune programming activities of Rh157.5 and Rh157.4 was sufficient to convert a wildtype-like RhCMV, with conventional MHC-Ia-restricted CD8 + T cell targeting, to a 68-1-like vector with exclusively MHC-IIand MHC-E-restricted CD8 + T cell responses. Using sequence information from primary RhCMV isolates, including the original 68-1 isolate 17, we reconstructed a full length RhCMV clone (RhCMV FL) in which all suspected deletions, inversions, frameshifts and premature termination codons affecting viral open reading frames were repaired and the Rh13.1 open reading frame (ORF) was replaced by an SIVgag insert (18). RhCMV FL has robust in vivo spread (18), and as expected for a wildtype genetic configuration (9), elicits MHC-Ia-restricted, CD8 + T cell responses ( Fig.…”
mentioning
confidence: 99%
“…Using sequence information from primary RhCMV isolates, including the original 68-1 isolate 17, we reconstructed a full length RhCMV clone (RhCMV FL) in which all suspected deletions, inversions, frameshifts and premature termination codons affecting viral open reading frames were repaired and the Rh13.1 open reading frame (ORF) was replaced by an SIVgag insert (18). RhCMV FL has robust in vivo spread (18), and as expected for a wildtype genetic configuration (9), elicits MHC-Ia-restricted, CD8 + T cell responses ( Fig. 2A).…”
mentioning
confidence: 99%
“…Second, and more important, the large and complex CMV genomes become available for prokaryotic recombination techniques, allowing for efficient and reliable gene targeting. In addition to multiple HCMV strains cloned as BACs (Wilkinson et al, 2015), animal CMV BACs are utilized as cloning platforms for in vitro and in vivo models and thereby provide the framework for a profound understanding of CMV infection and pathogenesis (Roark et al, 2020;Taher et al, 2020). In particular, the rhesus CMV (RhCMV) BAC platform has become a popular model system for HCMV due to many shared features in infection, replication and immune control (Itell et al, 2017;Powers and Früh, 2008).…”
Section: Introductionmentioning
confidence: 99%